Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Index level analysis helps pinpoint trend direction. This concise guide offers practical steps to identify and follow the prevailing trend.
20,762 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Bitcoin climbs after Trump suggests an Iran deal is near, sparking a risk-on move in crypto markets. Prices hit aroun...
As AI workloads push memory demand higher, micron stock could have substantial upside. Yet a high-capex Virginia expa...
A high-profile breakup can reshape more than headlines. Learn how earnings, branding, and money moves are affected an...
Arista Networks and AudioCodes sit at different points in the networking landscape. This article breaks down their bu...
A researcher from Apex Crypto argues XRP’s flat price path reflects more than market dynamics, pointing to Citibank d...
Credit to Credo Technology stock rose on a strong earnings beat, but the path ahead hinges on demand for AI infrastru...
Oracle reports a surge in cloud revenue and record backlog, but shares drift. Market talk centers on whether AI infra...
As Uber morphs into a multi-vertical platform, the real question for investors is how quickly it can translate growth...
In Q1 2026, Tepper’s Appaloosa slashed its Microsoft stake by about 82%, while Bill Ackman’s Pershing Square bought r...
When gas prices stay high, shoppers tighten belts and retailers with value-driven models often outperform. This artic...
A Capri Holdings director sold a sizable stake in a June 2026 open-market trade, triggering questions about motive an...